Design Therapeutics, Inc. (DSGN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Design Therapeutics, Inc. (DSGN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

DSGN Income Statement

Design Therapeutics, Inc. (DSGN) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	151K	0	-14.74M	14.59M	152K	0	0	0	151K	143K	0	137K	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-151K	0	14.74M	-14.59M	-152K	0	0	0	-151K	-143K	0	-137K	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.66%	-	-	-	-0.66%	100%	-	100%	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	22.03M	19.71M	32.91M	4.72M	21.42M	20.42M	16.69M	16.25M	14.89M	14.26M	15.12M	18.68M	22.6M	21.65M	19.39M	19.19M	15.64M	13.37M	11.13M	11.34M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	5.79M	5.33M	4.74M	4.72M	5.83M	5.04M	4.54M	4.37M	4.53M	4.6M	4.11M	5.57M	5.53M	5.92M	5.14M	4.89M	4.34M	4.61M	3.79M	2.8M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	16.39M	14.38M	13.43M	14.59M	15.74M	15.38M	12.16M	11.88M	10.37M	9.66M	11.01M	13.26M	17.06M	15.73M	14.26M	14.3M	11.29M	8.76M	7.34M	8.54M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-151K	0	1000K	-1000K	-152K	0	0	0	0	0	0	-137K	0	0	0	0	0	0	0	0
Operating Income	-22.18M	-19.71M	-18.17M	-19.31M	-21.57M	-20.42M	-16.69M	-16.25M	-15.04M	-14.4M	-15.12M	-18.82M	-22.6M	-21.65M	-19.39M	-19.19M	-15.64M	-13.37M	-11.13M	-11.34M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-2.82%	3.49%	-8.84%	-18.87%	-43.38%	-41.79%	-10.4%	13.69%	33.43%	33.49%	22.02%	1.93%	-44.48%	-61.94%	-74.28%	-69.29%	-103.45%	-135.39%	-188.19%	-
EBITDA	-22.03M	-19.55M	-18.01M	-19.16M	-21.42M	-20.26M	-16.55M	-16.09M	-14.89M	-14.26M	-14.98M	-18.68M	-22.46M	-21.52M	-19.27M	-19.08M	-15.55M	-13.29M	-11.04M	-11.31M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-2.84%	3.5%	-8.87%	-19.03%	-43.82%	-42.1%	-10.43%	13.87%	33.7%	33.76%	22.24%	2.09%	-44.48%	-61.97%	-74.45%	-68.8%	-102.57%	-134.11%	-186.36%	-
D&A (Non-Cash Add-back)	151K	157K	156K	155K	152K	159K	149K	153K	151K	143K	138K	137K	133K	129K	124K	108K	92K	82K	82K	31K
EBIT	-22.18M	-17.64M	-16M	-17M	-19.08M	-17.71M	-13.65M	-13.04M	-11.79M	-11.11M	-15.12M	-18.82M	-22.6M	-21.65M	-19.39M	-19.19M	-15.64M	-13.37M	-11.13M	-11.34M
Net Interest Income	2.01M	2.07M	2.17M	2.31M	2.49M	2.7M	3.04M	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	2.01M	2.07M	2.17M	2.31M	2.49M	2.7M	3.04M	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	2.01M	2.07M	2.17M	2.31M	2.49M	2.7M	3.04M	3.21M	3.25M	3.29M	3.28M	3.03M	2.66M	2.36M	2.05M	1.49M	640K	105K	62K	19K
Pretax Income	-20.16M	-17.64M	-16M	-17M	-19.08M	-17.71M	-13.65M	-13.04M	-11.79M	-11.11M	-11.84M	-15.79M	-19.94M	-19.29M	-17.34M	-17.7M	-15M	-13.27M	-11.06M	-11.32M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-20.16M	-17.64M	-16M	-17M	-19.08M	-17.71M	-13.65M	-13.04M	-11.79M	-11.11M	-11.84M	-15.79M	-19.94M	-19.29M	-17.34M	-17.7M	-15M	-13.27M	-11.06M	-11.32M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-5.67%	0.45%	-17.19%	-30.36%	-61.82%	-59.52%	-15.28%	17.42%	40.85%	42.44%	31.71%	10.82%	-32.92%	-45.45%	-56.71%	-56.42%	-96.42%	-140.57%	-187.03%	-
Net Income (Continuing)	-20.16M	-17.64M	-16M	-17M	-19.08M	-17.71M	-13.65M	-13.04M	-11.79M	-11.11M	-11.84M	-15.79M	-19.94M	-19.29M	-17.34M	-17.7M	-15M	-13.27M	-11.06M	-11.32M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.32	-0.29	-0.27	-0.30	-0.34	-0.31	-0.24	-0.23	-0.21	-0.20	-0.21	-0.28	-0.36	-0.30	-0.27	-0.29	-0.26	-0.24	-0.20	-0.21
EPS Growth %	5.88%	6.45%	-12.5%	-30.43%	-61.9%	-55%	-14.29%	17.86%	41.67%	33.33%	22.22%	3.45%	-38.46%	-25%	-35%	-38.1%	-85.71%	22.58%	-42.86%	-
EPS (Basic)	-0.32	-0.29	-0.27	-0.30	-0.34	-0.31	-0.24	-0.23	-0.21	-0.20	-0.21	-0.28	-0.36	-0.30	-0.27	-0.29	-0.26	-0.24	-0.20	-0.21
Diluted Shares Outstanding	62.51M	61.43M	57.33M	56.95M	56.86M	56.76M	56.68M	56.62M	56.56M	56.49M	56.15M	55.99M	55.95M	55.91M	55.86M	55.78M	55.67M	55.51M	55.36M	55.16M
Basic Shares Outstanding	62.51M	61.43M	57.33M	56.95M	56.86M	56.76M	56.68M	56.62M	56.56M	56.49M	56.15M	55.99M	55.95M	55.91M	55.86M	55.78M	55.67M	55.51M	55.36M	55.16M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-